FTC Suing To Stop Amgen’s $27.8 Billion Purchase Of Horizon Therapeutics
The FTC is attempting to stop the sale out of fears it will give the company too much power over rare disease treatments.
The FTC is attempting to stop the sale out of fears it will give the company too much power over rare disease treatments.
What's Your Reaction?
